OMH SCIENCE Group Co., Ltd (300486.SZ)
CNY 7.6
(0.0%)
CNY 7.6
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -207.03 Million | 51.78 Million | 104.46 Million | 55.61 Million | 12.51 Million | 8.91 Million |
| Net Income | -248.54 Million | 45.59 Million | 72.65 Million | 109.65 Million | 90.78 Million | 63.27 Million |
| Depreciation & Amortization | 43.5 Million | 40.12 Million | 42.29 Million | 32.24 Million | 30.62 Million | 25.67 Million |
| Deferred income taxes | -36.98 Million | -6.87 Million | -2.88 Million | -4.31 Million | -569.68 Thousand | -1.04 Million |
| Stock-based compensation | - | - | - | - | - | 147.58 Thousand |
| Change in working capital | -231.33 Million | -100.92 Million | -73.23 Million | -142.14 Million | -129.5 Million | -91.51 Million |
| Other non-cash items | 23.74 Million | 66.98 Million | 62.75 Million | 55.85 Million | 20.61 Million | 11.47 Million |
| Investing Cash Flow | 79.05 Million | -157.86 Million | -104.56 Million | -167.47 Million | -170.06 Million | -87.44 Million |
| Investments in PPE | -51.39 Million | -124.54 Million | -173.17 Million | -145.15 Million | -117.61 Million | -101.93 Million |
| Acquisitions | 49.33 Million | 6.68 Million | 84.35 Million | -28.59 Million | 117.81 Million | 1 Million |
| Investment purchases | -90 Million | -100 Million | -200 Thousand | -35.51 Million | -103.43 Million | -11.5 Million |
| Sales/Maturities of investments | 171.1 Million | 30.1 Million | 30.77 Million | 41.25 Million | 50.79 Million | 20.19 Million |
| Other Investing Activities | 130.44 Million | 29.88 Million | -46.31 Million | 535.17 Thousand | -117.61 Million | 4.78 Million |
| Financing Cash Flow | -21.27 Million | 469.16 Million | 21.91 Million | 103.86 Million | 275.9 Million | 52.27 Million |
| Debt repayment | -47.7 Million | -353.2 Million | -406.76 Million | -237.93 Million | -111.3 Million | -61 Million |
| Dividends payments | -4.87 Million | -7.31 Million | -10.84 Million | -9.93 Million | -6.32 Million | -9.52 Million |
| Common Stock Repurchased | - | - | - | - | - | -26.58 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -50.25 Million | 846.56 Million | 463.26 Million | 369.95 Million | 406.29 Million | 122.8 Million |
| Accounts receivables | -30.89 Million | -76.97 Million | -259.72 Million | -418.41 Million | -191.4 Million | -140.28 Million |
| Accounts payables | 136.16 Million | 12.86 Million | 90.44 Million | 120.77 Million | 25.46 Million | 85.74 Million |
| Inventory | -299.61 Million | -29.92 Million | 98.94 Million | 159.81 Million | 37.01 Million | -35.93 Million |
| Other working capital | 964.1 Thousand | -6.87 Million | -2.88 Million | -4.31 Million | -569.67 Thousand | -55.57 Million |
| Cash at beginning of period | 567.9 Million | 204.03 Million | 185.75 Million | 194.19 Million | 75.7 Million | 102.34 Million |
| Cash at end of period | 418.08 Million | 567.9 Million | 204.03 Million | 185.75 Million | 194.19 Million | 75.7 Million |
| Capital Expenditure | -51.39 Million | -124.54 Million | -173.17 Million | -145.15 Million | -117.61 Million | -101.93 Million |
| Effect of forex changes on cash | -560.87 Thousand | 796.4 Thousand | -3.53 Million | -445.79 Thousand | 128.91 Thousand | -383.8 Thousand |
| Net cash flow / Change in cash | -149.82 Million | 363.87 Million | 18.27 Million | -8.43 Million | 118.48 Million | -26.63 Million |
| Free Cash Flow | -258.43 Million | -72.76 Million | -68.71 Million | -89.53 Million | -105.09 Million | -93.01 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -34.4 Million | -36.17 Million | -6.41 Million | -241.42 Million | -248.54 Million | -44.85 Million |
| Depreciation & Amortization | - | 12.96 Million | 12.96 Million | 43.5 Million | 43.5 Million | 11.55 Million |
| Deferred income taxes | - | - | - | - | -36.98 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 182.9 Million | - | -329.54 Million | -231.33 Million | - |
| Other non-cash items | 16.43 Million | 44.54 Million | -64.68 Million | 514.91 Million | 23.74 Million | 59.43 Million |
| Investing Cash Flow | -20.4 Million | -20.78 Million | -23.65 Million | 27.64 Million | 79.05 Million | -6.96 Million |
| Investments in PPE | -21.02 Million | -9.44 Million | -3.68 Million | -2.86 Million | -51.39 Million | -18.18 Million |
| Acquisitions | 319.05 Thousand | 8.11 Million | 18.03 Thousand | 10.54 Million | 49.33 Million | 79.28 Thousand |
| Investment purchases | - | -40 Million | -20 Million | -20 Million | -90 Million | -20 Million |
| Sales/Maturities of investments | 306 Thousand | 20.53 Million | 12.27 Thousand | 39.96 Million | 171.1 Million | 31.14 Million |
| Other Investing Activities | 319.05 Thousand | -11.34 Million | -19.96 Million | 30.51 Million | 130.44 Million | 0.15 |
| Financing Cash Flow | -58.16 Million | 14.42 Million | 18.79 Million | 64.03 Million | -21.27 Million | -90.35 Million |
| Debt repayment | -48.53 Million | -101 Million | -31.62 Million | -81.4 Million | -47.7 Million | -91.2 Million |
| Dividends payments | -5.02 Million | -5.88 Million | -3.59 Million | -4.87 Million | -4.87 Million | -8.04 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -4.6 Million | -80.69 Million | -9.23 Million | -13.47 Million | -50.25 Million | 8.88 Million |
| Accounts receivables | - | 85.35 Million | - | -30.89 Million | -30.89 Million | - |
| Accounts payables | - | - | - | - | 136.16 Million | - |
| Inventory | - | 97.54 Million | - | -299.61 Million | -299.61 Million | - |
| Other working capital | - | - | - | 964.1 Thousand | 964.1 Thousand | - |
| Cash at beginning of period | 330.63 Million | 342.07 Million | 418.08 Million | 335.3 Million | 567.9 Million | 419.22 Million |
| Cash at end of period | 234.43 Million | 330.63 Million | 342.07 Million | 418.08 Million | 418.08 Million | 335.3 Million |
| Capital Expenditure | -21.02 Million | -9.44 Million | -3.68 Million | -2.86 Million | -51.39 Million | -18.18 Million |
| Effect of forex changes on cash | 439.98 Thousand | 41.98 Thousand | -41.2 Thousand | -59.92 Thousand | -560.87 Thousand | 20.09 Thousand |
| Net cash flow / Change in cash | -96.2 Million | -11.44 Million | -76 Million | 82.77 Million | -149.82 Million | -83.92 Million |
| Free Cash Flow | -38.99 Million | -14.02 Million | -74.79 Million | -15.41 Million | -258.43 Million | -3.6 Million |
DNA
EGS745W1C011
603963
IDEXF
TURSG
NIKHILAD